Literature DB >> 23054126

Catheter ablation of atrial fibrillation: the need for studies to assess the efficacy and safety of novel anticoagulants.

Gerald V Naccarelli1, Mario D Gonzalez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23054126     DOI： 10.1007/s10840-012-9720-3

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN： 1383-875X            Impact factor:   1.900


× No keyword cloud information.
  7 in total

1.  Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry.

Authors:  Dhanunjaya Lakkireddy; Yeruva Madhu Reddy; Luigi Di Biase; Subba Reddy Vanga; Pasquale Santangeli; Vijay Swarup; Rhea Pimentel; Moussa C Mansour; Andre D'Avila; Javier E Sanchez; J David Burkhardt; Fadi Chalhoub; Prasant Mohanty; James Coffey; Naushad Shaik; George Monir; Vivek Y Reddy; Jeremy Ruskin; Andrea Natale
Journal:  J Am Coll Cardiol       Date:  2012-02-01       Impact factor: 24.094

2.  The use of dabigatran immediately after atrial fibrillation ablation.

Authors:  Roger A Winkle; R Hardwin Mead; Gregory Engel; Melissa H Kong; Rob A Patrawala
Journal:  J Cardiovasc Electrophysiol       Date:  2011-09-28

3.  Catheter ablation for atrial fibrillation on uninterrupted warfarin: can it be done without echo guidance?

Authors:  Stephen P Page; M Shoaib Siddiqui; Malcolm Finlay; Ross J Hunter; Dominic J Abrams; Mehul Dhinoja; Mark J Earley; Simon C Sporton; Richard J Schilling
Journal:  J Cardiovasc Electrophysiol       Date:  2010-10-06

4.  Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation.

Authors:  Hakan Oral; Aman Chugh; Mehmet Ozaydin; Eric Good; Jackie Fortino; Sundar Sankaran; Scott Reich; Petar Igic; Darryl Elmouchi; David Tschopp; Alan Wimmer; Sujoya Dey; Thomas Crawford; Frank Pelosi; Krit Jongnarangsin; Frank Bogun; Fred Morady
Journal:  Circulation       Date:  2006-08-14       Impact factor: 29.690

5.  Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period.

Authors:  Oussama M Wazni; Salwa Beheiry; Tamer Fahmy; Conor Barrett; Steven Hao; Dimpi Patel; Luigi Di Biase; David O Martin; Mohamed Kanj; Mauricio Arruda; Jennifer Cummings; Robert Schweikert; Walid Saliba; Andrea Natale
Journal:  Circulation       Date:  2007-11-12       Impact factor: 29.690

6.  Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy.

Authors:  Ayman A Hussein; David O Martin; Walid Saliba; Deven Patel; Saima Karim; Omar Batal; Mustafa Banna; Michelle Williams-Andrews; Minerva Sherman; Mohamed Kanj; Mandeep Bhargava; Thomas Dresing; Thomas Callahan; Patrick Tchou; Luigi Di Biase; Salwa Beheiry; Bruce Lindsay; Andrea Natale; Oussama Wazni
Journal:  Heart Rhythm       Date:  2009-07-10       Impact factor: 6.343

7.  A comparison of bleeding complications post-ablation between warfarin and dabigatran.

Authors:  David Snipelisky; Christine Kauffman; Karin Prussak; Gretchen Johns; K Venkatachalam; Fred Kusumoto
Journal:  J Interv Card Electrophysiol       Date:  2012-08-07       Impact factor: 1.900
  7 in total
  4 in total

1.  Detection of left atrial thrombus by intracardiac echocardiography in patients undergoing ablation of atrial fibrillation.

Authors:  Chenni S Sriram; Javier E Banchs; Talal Moukabary; Raman Moradkhan; Mario D Gonzalez
Journal:  J Interv Card Electrophysiol       Date:  2015-05-03       Impact factor: 1.900

Review 2.  Meta-analysis of efficacy and safety of apixaban and uninterrupted apixaban therapy compared to vitamin K antagonists in patients undergoing catheter ablation for atrial fibrillation.

Authors:  Anene Ukaigwe; Pragya Shrestha; Paras Karmacharya; Sarah K Hussain; Soraya Samii; Mario D Gonzalez; Deborah Wolbrette; Gerald V Naccarrelli
Journal:  J Interv Card Electrophysiol       Date:  2016-10-22       Impact factor: 1.900

3.  Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation.

Authors:  Riccardo Cappato; Francis E Marchlinski; Stefan H Hohnloser; Gerald V Naccarelli; Jim Xiang; David J Wilber; Chang-Sheng Ma; Susanne Hess; Darryl S Wells; George Juang; Johan Vijgen; Burkhard J Hügl; Richard Balasubramaniam; Christian De Chillou; D Wyn Davies; L Eugene Fields; Andrea Natale
Journal:  Eur Heart J       Date:  2015-05-14       Impact factor: 29.983

Review 4.  Periprocedural Use of Oral Anticoagulation Therapy in Patients Undergoing Atrial Fibrillation Ablation.

Authors:  Ilir Maraj; Mario D Gonzalez; Gerald V Naccarelli
Journal:  J Innov Card Rhythm Manag       Date:  2018-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.